6 results about "Autistic spectrum" patented technology

FIELD: neurology; psychiatry.SUBSTANCE: used as a non-pharmacological therapy for autism spectrum disorders in children. The method includes a set of procedures: interval hypoxic-hyperoxic training (HHT), hyperbaric oxygenation and ozone therapy. HHT consists of alternating inhalations of a hypoxic mixture with an oxygen content of 9 to 16 vol.% and a hyperoxic mixture with an oxygen content of 32 to 40 vol.% for a total duration of 45-50 minutes under the control of cardiovascular system parameters. Hyperbaric oxygenation is performed in a pressure chamber under a pressure of 1.3 atmospheres of 100% oxygen mixture, flow of 10 liters per minute, for 45 minutes using a mask. Ozone therapy is performed by rectal insufflation with an ozone-oxygen mixture with an ozone concentration of 85 μg / ml in a volume of 20–30 ml or by intravenous administration of a physiological solution enriched with ozone with an ozone concentration of 85 μg / ml at a rate of 200 ml per 100 ml of physiological solution. The procedures are carried out daily for 12 days.EFFECT: method is effective and has a positive impact on the patient’s condition.1 cl, 1 dwg, 3 ex

Exemplary method for strength-based coping training includes (a) prompting user, by a software application operable on a computing device, to identify at least one of their top character strengths from a preset list of character strengths, the preset list of character strengths being identified in a character strengths database; (b) receiving from the user in response, a selection of at least one of their top character strengths from the preset list of character strengths; (c) processing the received selection of the user's top character strengths to identify different coping strategies from a coping strategy database that the user may wish to consider, wherein identification of the different coping strategies being based on the received user's top character strengths selection; and (d) the software application providing to the computing device information for presenting, or making accessible, to the user the identified different coping strategies that the user may wish to consider.

The invention discloses application of allyl isothiocyanate in preparation of drugs or health-care foods for improving mental disorder, and belongs to the technical field of medicines. Allyl isothiocyanate shows rapid, convenient and efficient intervention potential for depression, emotional disorder, social difficulty, biphasic emotional fluctuation, anxiety and autism spectrum symptoms when used as a functional component of a medicine or health food. Specific experiments verify that in a depression model constructed by adopting social contusion stress, the component can obviously reverse typical depression-like behaviors such as social avoidance tendency and behavioral despair states shown by mice. In a chronic unpredictable stress induced model, allyl isothiocyanate effectively relieves anxiety and depression symptoms of mice and recovers pleasant sensation experience ability of the mice. In a drug-induced bipolar affective disorder model, the component obviously stabilizes the manic attack and depression alternating behavior of mice. In an autism model mouse, the allyl isothiocyanate effectively relieves the repetitive engraving behavior of the autism model mouse.

The application discloses application of allyl isothiocyanate in preparation of a medicine for improving mental disorders and belongs to the technical field of medicines. The application of allyl isothiocyanate in preparation of a medicine for improving mental disorders has a rapid, convenient and efficient intervention potential for depression, emotional disorder, social difficulty, bipolar emotional fluctuation, anxiety and autism spectrum symptoms. Specific experimental verification: in a depression model constructed by using social frustration stress, the component can obviously reverse typical depression-like behaviors of the mouse, such as social avoidance tendency and behavior despair state. In a model induced by chronic unpredictable stress, allyl isothiocyanate effectively relieves anxiety and depression symptoms of the mouse and restores the hedonic experience ability of the mouse. In a medicine-induced bipolar affective disorder model, the component significantly suppresses the mania onset and depression alternating behavior of the mouse. In a mouse model of autism, allyl isothiocyanate effectively relieves the repetitive stereotyped behavior of the mouse.

The invention relates to the treatment of cannabidiol for autistic spectrum disorders. A method of treating one or more behavioral symptoms of autism spectrum disorder (ASD) in a patient by administering to the patient an effective amount of cannabidiol (CBD) wherein the one or more behavioral symptoms of ASD are treated.

A computer-implemented method, system, and computer program product for emotion recognition. A deep convolutional neural network is trained to identify an emotion from images of facial expressions. Furthermore, an application in a computing device (e.g., mobile computing device, such as a smartphone) is utilized to capture an image of an individual (e.g., individual that is neurotypical, individual on the autism spectrum). The captured image of the individual is then analyzed using the trained deep convolutional neural network. The emotional state of the individual is then classified based on the analysis of the captured image of the individual using the trained deep convolutional neural network. The classified emotional state is then conveyed to a user (e.g., neurotypical individual, autistic individual) via an emoticon (emotional icon), such that the emoticon reflects the classified emotional state.